Science
Mechanism of Action
Inhibits melanogenesis by suppressing tyrosinase enzyme activity, preventing excess melanin formation. Simultaneously activates the Nrf2 antioxidant pathway to neutralize free radicals and blocks inflammatory COX-2 and NF-κB signaling cascades.
Research
Clinical Evidence
High confidence3%
Key findings
- 01 12-week split-face study: 3% concentration matched 4% hydroquinone efficacy for dark spots and luminosity by week 8
- 02 90-day melasma study: 1-3% concentration significantly reduced MASI scores comparable to prescription hydroquinone without adverse effects
Transparency
Dusting Analysis
Clinical studies demonstrate meaningful results at 1-3% concentrations, making sub-0.5% levels likely ineffective for brightening benefits.
The Formula
Formulation
Stability
Protein components show reduced solubility at pH 4.0-5.0 (isoelectric point). Most stable in slightly acidic to neutral environments.
Synergies
- vitamin C
- niacinamide
- kojic acid
Conflicts
- strong oxidizing agents
- high alkaline ingredients
Safety
Safety Profile
GRAS status for consumption. EWG rates as low-hazard (Score 1). Commercial formulations typically limit to 5% maximum.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Clinically-validated hydroquinone alternative with excellent safety profile and universal skin type compatibility.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources